CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

about

Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?

P2860

Q55515297-1A73B5D6-EE48-4D7B-A1E6-CB8C4C84F14C

P2860

CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

Item

http://www.wikidata.org/entity/Q52666918

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@en

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@nl

type

Item

label

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@en

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@nl

prefLabel

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@en

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing.

@nl

P1476

CEP72-ROS1: A novel ROS1 oncog ...... by next-generation sequencing

@en

P2093

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Kai-Qi Du

http://www.w3.org/2001/XMLSchema#string

Wu Zhuang

http://www.w3.org/2001/XMLSchema#string

You-Cai Zhu

http://www.w3.org/2001/XMLSchema#string

Yue-Fen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

ROS1 rearrangements define a unique molecular class of lung cancers.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

Comprehensive molecular profiling of lung adenocarcinoma.

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.

The centriolar satellite proteins Cep72 and Cep290 interact and are required for recruitment of BBS proteins to the cilium.

Clinical Implications of Variant ALK FISH Rearrangement Patterns.

Recent Advances in Targeting ROS1 in Lung Cancer.

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

P304

652-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/1759-7714.12617

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wen-Xian Wang

Chun-Wei Xu

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29517860

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5928353

http://www.w3.org/2001/XMLSchema#string

CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

about

P2860

P2860

CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932